CM-444

N/A

Report date: 2023/03/11 18:02:23
NME

Base Information

Drug NameCM-444
Drug Alias NameCM-444
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase inhibitorsDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsHistone deacetylaseDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Navarra
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Navarra
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A